Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $31.1000 (-2.81%) ($31.1000 - $31.8000) on Fri. Nov. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.25% (three month average) | RSI | 66 | Latest Price | $31.1000(-2.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 6.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IPO(8%) SKYY(8%) PEJ(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.125% in a week (0% probabilities). TLT(-6%) GDX(-6%) VIXM(-5%) SLV(-5%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.125% (StdDev 4.25%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $31.61(-1.61%) | 10 Day Moving Average | $30.74(1.17%) | 20 Day Moving Average | $29.64(4.93%) | To recent high | -24% | To recent low | 16.9% | Market Cap | $613m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |